ANTITHROMBOTIC EFFICACY OF LOW-MOLECULAR-WEIGHT HEPARIN KABI

被引:0
|
作者
HAAS, S
STEMBERGER, A
FRITSCHE, HM
LECHNER, F
机构
来源
MEDIZINISCHE WELT | 1987年 / 38卷 / 20期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:714 / 720
页数:7
相关论文
共 50 条
  • [21] COMPARISON OF THE ANTITHROMBOTIC, ANTICLOTTING AND ANTIPLATELET AGGREGATORY ACTIVITIES OF LOW-MOLECULAR-WEIGHT RD HEPARIN WITH HEPARIN
    FENICHEL, RL
    CARMINT, W
    SMALL, B
    WILLIS, J
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 554 - 554
  • [22] BLEEDING AND ANTITHROMBOTIC EFFECTS OF A LOW-MOLECULAR-WEIGHT HEPARIN (LMW/OP 2123)
    PARMA, B
    BIANCHINI, P
    OSIMA, B
    THROMBOSIS RESEARCH, 1986, : 95 - 95
  • [23] Antithrombotic therapy in coronary ischaemia: The expanding role of low-molecular-weight heparin
    Turpie, AGG
    HAEMOSTASIS, 1998, 28 : 35 - 42
  • [24] THROMBOSIS PROPHYLAXIS WITH LOW-MOLECULAR-WEIGHT HEPARIN (KABI 2165) AND CALCIUM HEPARIN IN PATIENTS WITH TOTAL HIP-REPLACEMENT
    POTRON, G
    BARRE, J
    DROULLE, C
    BAUDRILLARD, JC
    BARBIER, P
    KHER, A
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 118 - 118
  • [25] EFFICACY OF LOW-MOLECULAR-WEIGHT HEPARIN IN THE MANAGEMENT OF INTERMITTENT CLAUDICATION
    MANNARINO, E
    PASQUALINI, L
    INNOCENTE, S
    ORLANDI, U
    SCRICCIOLO, V
    LOMBARDINI, R
    CIUFFETTI, G
    ANGIOLOGY, 1991, 42 (01) : 1 - 7
  • [26] Efficacy of low-molecular-weight heparin in acute coronary syndromes
    Wallentin, L
    AMERICAN HEART JOURNAL, 2000, 139 (02) : S29 - S32
  • [27] A COMPARISON BETWEEN LOW-MOLECULAR-WEIGHT HEPARIN (KABI-2165) AND STANDARD HEPARIN IN THE INTRAVENOUS TREATMENT OF DEEP VENOUS THROMBOSIS
    BRATT, G
    TORNEBOHM, E
    GRANQVIST, S
    ABERG, W
    LOCKNER, D
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (04) : 813 - 817
  • [28] A COMPARISON OF THE ANTITHROMBOTIC AND HEMORRHAGIC EFFECTS OF A LOW-MOLECULAR-WEIGHT HEPARIN (LHN-1) AND CONVENTIONAL HEPARIN
    DINESS, V
    NIELSEN, JI
    PEDERSEN, PC
    WOLFFBRANDT, KH
    OSTERGAARD, PB
    THROMBOSIS AND HAEMOSTASIS, 1986, 55 (03) : 410 - 414
  • [29] THE ROLE OF TISSUE FACTOR PATHWAY INHIBITOR IN THE MEDIATION OF THE ANTITHROMBOTIC ACTIONS OF HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN
    HOPPENSTEADT, DA
    JESKE, W
    FAREED, J
    BERMES, EW
    BLOOD COAGULATION & FIBRINOLYSIS, 1995, 6 : S57 - S64
  • [30] Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis
    Harenberg, J
    Stehle, G
    Blauth, M
    Huck, K
    Mall, K
    Heene, DL
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (01): : 83 - 90